Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Using an Antibiotic Treatment Called Amikacin Liposome Inhalation Suspension (or ALIS) for Chronic Infection With Pseudomonas aeruginosa in People With Cystic Fibrosis for 2 years

Using an Antibiotic Treatment Called Amikacin Liposome Inhalation Suspension (or ALIS) for Chronic Infection With Pseudomonas aeruginosa in People With Cystic Fibrosis for 2 years

Resource Type

CF Research News

Authors

Diana Bilton, Isabelle Fajac, Tacjana Pressler, John Paul Clancy, Dorota Sands, Predrag Minic, Marco Cipolli, Ivanka Galeva, Amparo Solé, Alexandra L Quittner, Zhanna Jumadilova, Monika Ciesielska, Michael W Konstan, CLEAR-110 Study Group

References

J Cyst Fibros. 2021 Jun 15;S1569-1993(21)00164-8. doi: 10.1016/j.jcf.2021.05.013.

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Keywords

ALIS [3]
Amikacin [4]
Liposomal [5]
Pseudomonas aeruginosa [6]

Date

Tuesday, June 15, 2021

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [7]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/using-antibiotic-treatment-called-amikacin-liposome-inhalation

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-20-00517R1_FINAL_Konstan_290821.pdf [2] https://pubmed.ncbi.nlm.nih.gov/34144923/ [3] https://www.ecfs.eu/research-article-keywords/alis [4] https://www.ecfs.eu/research-article-keywords/amikacin [5] https://www.ecfs.eu/research-article-keywords/liposomal [6] https://www.ecfs.eu/research-article-keywords/pseudomonas-aeruginosa [7] https://www.ecfs.eu/resource-guideline-type/other-guidelines